A citation-based method for searching scientific literature

Virginia Soria, Alexandre González-Rodríguez, Elena Huerta-Ramos, Judith Usall, Jesús Cobo, Miquel Bioque, Juan David Barbero, Clemente García-Rizo, Meritxell Tost, José Antonio Monreal, Javier Labad. Psychoneuroendocrinology 2018
Times Cited: 46







List of co-cited articles
259 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.
J Keller, R Gomez, G Williams, A Lembke, L Lazzeroni, G M Murphy, A F Schatzberg. Mol Psychiatry 2017
305
17

The HPA axis in bipolar disorder: Systematic review and meta-analysis.
Martino Belvederi Murri, Davide Prestia, Valeria Mondelli, Carmine Pariante, Sara Patti, Benedetta Olivieri, Costanza Arzani, Mattia Masotti, Matteo Respino, Marco Antonioli,[...]. Psychoneuroendocrinology 2016
178
13

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia.
T W Weickert, D Weinberg, R Lenroot, S V Catts, R Wells, A Vercammen, M O'Donnell, C Galletly, D Liu, R Balzan,[...]. Mol Psychiatry 2015
95
10

A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression.
Stuart Watson, Peter Gallagher, Richard J Porter, Margaret S Smith, Lisa J Herron, Samantha Bulmer, Allan H Young, I Nicol Ferrier. Biol Psychiatry 2012
88
10


The HPA axis in major depression: classical theories and new developments.
Carmine M Pariante, Stafford L Lightman. Trends Neurosci 2008
10

Hypothalamic-pituitary-adrenal axis-related genes and cognition in major mood disorders and schizophrenia: a systematic review.
Alex Ferrer, Javier Labad, Neus Salvat-Pujol, José A Monreal, Mikel Urretavizcaya, José M Crespo, José M Menchón, Diego Palao, Virginia Soria. Prog Neuropsychopharmacol Biol Psychiatry 2020
12
41



Prolactin concentrations in antipsychotic-naïve patients with schizophrenia and related disorders: A meta-analysis.
Leticia González-Blanco, Anne Marie D Greenhalgh, Clemente Garcia-Rizo, Emilio Fernandez-Egea, Brian J Miller, Brian Kirkpatrick. Schizophr Res 2016
46
8


Cognitive Function and Serum Hormone Levels Are Associated with Gray Matter Volume Decline in Female Patients with Prolactinomas.
Shun Yao, Jian Song, Junfeng Gao, Pan Lin, Ming Yang, Kashif Rafiq Zahid, Yan Yan, Chenglong Cao, Pan Ma, Hui Zhang,[...]. Front Neurol 2018
23
17

Increased prolactin levels are associated with impaired processing speed in subjects with early psychosis.
Itziar Montalvo, Alfonso Gutiérrez-Zotes, Marta Creus, Rosa Monseny, Laura Ortega, Joan Franch, Stephen M Lawrie, Rebecca M Reynolds, Elisabet Vilella, Javier Labad. PLoS One 2014
26
15

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis.
A Riecher-Rössler, J K Rybakowski, M O Pflueger, R Beyrau, R S Kahn, P Malik, W W Fleischhacker. Psychol Med 2013
56
8

Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
Mark Weiser, Linda Levi, Shimon Burshtein, Michal Hagin, Valentin P Matei, Delia Podea, Ioana Micluția, Alexandru Tiugan, Bogdan Păcală, Iosif Gabos Grecu,[...]. J Clin Psychiatry 2017
28
14


Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis.
Jelle V Zorn, Remmelt R Schür, Marco P Boks, René S Kahn, Marian Joëls, Christiaan H Vinkers. Psychoneuroendocrinology 2017
320
8

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.
Allan H Young, Peter Gallagher, Stuart Watson, Dolores Del-Estal, Bruce M Owen, I Nicol Ferrier. Neuropsychopharmacology 2004
229
8

Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response.
James P Herman, Jessica M McKlveen, Sriparna Ghosal, Brittany Kopp, Aynara Wulsin, Ryan Makinson, Jessie Scheimann, Brent Myers. Compr Physiol 2016
685
8


The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
6

Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.
Valeria Mondelli, Carmine M Pariante, Serena Navari, Monica Aas, Alessandro D'Albenzio, Marta Di Forti, Rowena Handley, Nilay Hepgul, Tiago Reis Marques, Heather Taylor,[...]. Schizophr Res 2010
90
6

Prolactin in response to acute psychosocial stress in healthy men and women.
Anna-Karin Lennartsson, Ingibjörg H Jonsdottir. Psychoneuroendocrinology 2011
91
6

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.
Brian J Miller, Peter Buckley, Wesley Seabolt, Andrew Mellor, Brian Kirkpatrick. Biol Psychiatry 2011
6

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.
Valeria Mondelli, Annamaria Cattaneo, Martino Belvederi Murri, Marta Di Forti, Rowena Handley, Nilay Hepgul, Ana Miorelli, Serena Navari, Andrew S Papadopoulos, Katherine J Aitchison,[...]. J Clin Psychiatry 2011
204
6

Salivary cortisol in early psychosis: New findings and meta-analysis.
Boris Chaumette, Oussama Kebir, Célia Mam-Lam-Fook, Yannick Morvan, Julie Bourgin, Bill P Godsil, Marion Plaze, Raphaël Gaillard, Thérèse M Jay, Marie-Odile Krebs. Psychoneuroendocrinology 2016
56
6


Meta-analysis of oxidative stress in schizophrenia.
Joshua Flatow, Peter Buckley, Brian J Miller. Biol Psychiatry 2013
301
6


Improvement in cognitive abilities following cabergoline treatment in patients with a prolactin-secreting pituitary adenoma.
Itziar Montalvo, Marta Llorens, Laia Caparrós, Montserrat Pamias, Jordi Torralbas, Olga Giménez-Palop, Assumpta Caixàs, Diego J Palao, Javier Labad. Int Clin Psychopharmacol 2018
6
50


The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity.
Sonia J Lupien, Robert-Paul Juster, Catherine Raymond, Marie-France Marin. Front Neuroendocrinol 2018
126
6

The relationship of sex hormones and cortisol with cognitive functioning in Schizophrenia.
R Halari, V Kumari, R Mehrotra, M Wheeler, M Hines, T Sharma. J Psychopharmacol 2004
54
6

Multiple measures of HPA axis function in ultra high risk and first-episode schizophrenia patients.
Dorte Nordholm, Egill Rostrup, Valeria Mondelli, Lasse Randers, Mette Ø Nielsen, Sanne Wulff, Henrik Nørbak-Emig, Brian V Broberg, Kristine Krakauer, Paola Dazzan,[...]. Psychoneuroendocrinology 2018
16
18

Estimating the true global burden of mental illness.
Daniel Vigo, Graham Thornicroft, Rifat Atun. Lancet Psychiatry 2016
910
6

Sex differences in the relationship between prolactin levels and impaired processing speed in early psychosis.
Itziar Montalvo, Roser Nadal, Antonio Armario, Alfonso Gutiérrez-Zotes, Marta Creus, Ángel Cabezas, Montse Solé, Maria José Algora, Vanessa Sánchez-Gistau, Elisabet Vilella,[...]. Aust N Z J Psychiatry 2018
8
37

Cognitive functioning of patients with a PRL-secreting pituitary adenoma: A preliminary report.
Aleksandra Bala, Emilia Łojek, Andrzej Marchel. Neurology 2016
25
12




Don't stress about CRF: assessing the translational failures of CRF1antagonists.
Samantha R Spierling, Eric P Zorrilla. Psychopharmacology (Berl) 2017
91
6

Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
Elena Huerta-Ramos, Raquel Iniesta, Susana Ochoa, Jesús Cobo, Eva Miquel, Mercedes Roca, Antoni Serrano-Blanco, Fernando Teba, Judith Usall. Eur Neuropsychopharmacol 2014
55
6

The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis.
Janna de Boer, Merel Prikken, Wan U Lei, Marieke Begemann, Iris Sommer. NPJ Schizophr 2018
38
7

Serum testosterone levels are related to cognitive function in men with schizophrenia.
L Moore, M Kyaw, A Vercammen, R Lenroot, J Kulkarni, J Curtis, M O'Donnell, V J Carr, C Shannon Weickert, T W Weickert. Psychoneuroendocrinology 2013
59
6

Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Judith Usall, Elena Huerta-Ramos, Javier Labad, Jesús Cobo, Christian Núñez, Marta Creus, Gemma García Parés, Daniel Cuadras, José Franco, Eva Miquel,[...]. Schizophr Bull 2016
42
7

Testosterone, DHEA and DHEA-S in patients with schizophrenia: A systematic review and meta-analysis.
Błażej Misiak, Dorota Frydecka, Olga Loska, Ahmed A Moustafa, Jerzy Samochowiec, Justyna Kasznia, Bartłomiej Stańczykiewicz. Psychoneuroendocrinology 2018
33
9

Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions.
Jeehae Sun, Adam J Walker, Brian Dean, Maarten van den Buuse, Andrea Gogos. Psychoneuroendocrinology 2016
44
6

Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.
Javier Labad, Lourdes Martorell, Elena Huerta-Ramos, Jesús Cobo, Elisabet Vilella, Elena Rubio-Abadal, Gemma Garcia-Pares, Marta Creus, Cristian Núñez, Laura Ortega,[...]. Eur Neuropsychopharmacol 2016
18
16


Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.
C Gurvich, A Hudaib, E Gavrilidis, R Worsley, N Thomas, J Kulkarni. Psychoneuroendocrinology 2019
15
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.